Simplexia is develops vaccine against herpes simplex virus type (HSV-2) infection, which is the most common sexually transmitted infection in the world. The infection causes genital herpes with painful and recurrent genital blisters. HSV-2 can also cause life-threatening encephalitis and meningitis in newborns and immunocompromised patients. A major issue is that HSV-2 infected patients also suffer a three-fold increased risk of HIV acquisition.
View Top Employees from SimplexiaWebsite | http://www.simplexia.se |
Employees | 4 (1 on RocketReach) |
Technologies | |
Industry | Biotechnology Research |
Looking for a particular Simplexia employee's phone or email?
Dmitry Shkumat is the partner of Simplexia.
1 people are employed at Simplexia.